Healthcare -
Biotechnology - NYSE - US
$ 4.9993
2.24 %
$ 69 M
Market Cap
-1.18
P/E
ANVS - OPERATING EXPENSES
Operating Expenses ANVS - Annovis Bio, Inc.
45 M
LAST VALUE
76.23%
2 YEAR CAGR
129.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR